PhenoVista

San Diego, United States Founded: 2014 • Age: 12 yrs
A CRO that provides phenotypic assay development and screening services.
Request Access

About PhenoVista

PhenoVista is a company based in San Diego (United States) founded in 2014.. PhenoVista has raised $3 million across 4 funding rounds from investors including Fujifilm and HHS. PhenoVista offers products and services including Custom Services, Ready-2-Go Assays, Cell Painting & Screening, and Imaging & Analysis. PhenoVista operates in a competitive market with competitors including Reaction Biology, ImmunoSCAPE, Discovery Biomed, BCI Pharma and ICE Bioscience, among others.

  • Headquarter San Diego, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Phenovista Biosciences
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3 M (USD)

    in 4 rounds

  • Latest Funding Round
    $3 M (USD), Seed

    Jan 10, 2023

  • Investors
    Fujifilm

    & 1 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PhenoVista

PhenoVista offers a comprehensive portfolio of products and services, including Custom Services, Ready-2-Go Assays, Cell Painting & Screening, and Imaging & Analysis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Tailored assays for specific drug discovery needs

Off-the-shelf solutions for immediate research use

Techniques for visualizing and screening cellular responses

Advanced imaging to provide quantitative biological insights

People of PhenoVista
Headcount 10-50
Employee Profiles 8
Employee Profiles
People
Anthony Essex
CSO
People
Marshall Peterman
Associate Director Of Scientific Operations
People
Reese Prentice
Associate Scientist I
People
Nimesha Tadepalle
Scientist III

Unlock access to complete

Funding Insights of PhenoVista

PhenoVista has successfully raised a total of $3M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $3 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Seed — $3.0M
  • First Round

    (15 Sep 2017)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2023 Amount Seed - PhenoVista Valuation

investors

Dec, 2022 Amount Seed - PhenoVista Valuation

investors

Feb, 2021 Amount Grant - PhenoVista Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in PhenoVista

PhenoVista has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Fujifilm and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Multiple sectors are invested in by the venture capital firm.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by PhenoVista

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - PhenoVista

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Phenovista Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of PhenoVista

PhenoVista operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Reaction Biology, ImmunoSCAPE, Discovery Biomed, BCI Pharma and ICE Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
domain founded_year HQ Location
High-dimensional immune profiling services are delivered via proprietary platform.
domain founded_year HQ Location
Custom human cell engineering and drug discovery services are provided.
domain founded_year HQ Location
Contract research services in cancer and neuroinflammation are offered.
domain founded_year HQ Location
Specialised CRO offering a range of screening platforms for cardiac safety testing, ion channel profiling and in vitro HTS screening
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about PhenoVista

When was PhenoVista founded?

PhenoVista was founded in 2014 and raised its 1st funding round 3 years after it was founded.

Where is PhenoVista located?

PhenoVista is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Is PhenoVista a funded company?

PhenoVista is a funded company, having raised a total of $3M across 4 funding rounds to date. The company's 1st funding round was a Grant of $249.9K, raised on Sep 15, 2017.

What does PhenoVista do?

PhenoVista was founded in 2014 and is based in San Diego, United States. Operations are centered in the biotechnology sector as a contract research organization. Services encompass phenotypic assay development and high-throughput screening, with emphasis on functional neuronal assays utilizing iPS-derived neurons, embryonic stem cell differentiation, human inflammation models, and myotube formation processes. These capabilities support drug discovery efforts in neuroscience and related fields.

Who are the top competitors of PhenoVista?

PhenoVista's top competitors include ImmunoSCAPE, Quantumcyte and Reaction Biology.

What products or services does PhenoVista offer?

PhenoVista offers Custom Services, Ready-2-Go Assays, Cell Painting & Screening, and Imaging & Analysis.

Who are PhenoVista's investors?

PhenoVista has 2 investors. Key investors include Fujifilm, and HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available